GRADE Evidence Profile for insulin glargine versus non-glargine insulin.
收藏NIAID Data Ecosystem2026-03-07 收录
数据链接：
官方服务：
资源简介：
*Only some studies presenting effect estimates adjusted for known confounders. †High heterogeneity among studies. ‡95% confidence interval around the pooled includes both 1) no effect and 2) appreciable benefit and appreciable harm. §Although we did not downgrade, publication bias cannot be excluded. ∥95% confidence interval around the pooled includes both 1) no effect and 2) appreciable harm. ¶95% confidence interval around the pooled includes both 1) no effect and 2) appreciable benefit.
创建时间：
2012-12-19
